Health
Newly approved drugs in Canada lack key pediatric drug information – News-Medical.Net
Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children’s Hospital.
Reviewed by Emily Henderson, B.Sc.Sep 1 2020
Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children’s Hospital.
This absence of pediatric information perpetuates “off-label” drug use which could be dangerous for this vulnerable population, say the authors. They add that Canadian regulatory mechanisms are needed to ensure submission of pediatric data by manufacturers when use …
-
Noosa News14 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
Noosa News23 hours agoE-Scooter accident | Noosa Today
-
Business15 hours ago3 ASX ETFs that could be perfect for beginners
-
General22 hours agoOutback Farm stars finish first barley harvest at Central Australian farm